These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 35567766)
1. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort. Pilling LC; Atkins JL; Melzer D Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766 [TBL] [Abstract][Full Text] [Related]
2. Penetrance of the C28Y/C282Y genotype of the HFE gene. Asberg A; Hveem K; Kannelønning K; Irgens WØ Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673 [TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216 [TBL] [Abstract][Full Text] [Related]
5. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy. Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665 [TBL] [Abstract][Full Text] [Related]
6. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997 [TBL] [Abstract][Full Text] [Related]
7. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861 [TBL] [Abstract][Full Text] [Related]
8. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study. Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402 [TBL] [Abstract][Full Text] [Related]
10. Hereditary Hemochromatosis Variant Associations with Incident Nonliver Malignancies: 11-Year Follow-up in UK Biobank. Atkins JL; Pilling LC; Torti SV; Torti FM; Kuchel GA; Melzer D Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1780-1787. PubMed ID: 35709753 [TBL] [Abstract][Full Text] [Related]
11. Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Burke W; Imperatore G; McDonnell SM; Baron RC; Khoury MJ Genet Med; 2000; 2(5):271-7. PubMed ID: 11399207 [TBL] [Abstract][Full Text] [Related]
14. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis. Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080 [TBL] [Abstract][Full Text] [Related]
15. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
16. HFE genotype in patients with hemochromatosis and other liver diseases. Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365 [TBL] [Abstract][Full Text] [Related]
17. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC; Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211 [TBL] [Abstract][Full Text] [Related]
18. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799 [TBL] [Abstract][Full Text] [Related]
19. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Gleeson F; Ryan E; Barrett S; Crowe J Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409 [TBL] [Abstract][Full Text] [Related]
20. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis. Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]